COMPARATIVE EVALUATION OF POST OPERATIVE ANALGESIC EFFECTS OF WOUND INFILTRATION WITH ROPIVACAINE VERSUS LEVOBUPIVACAINE IN MODIFIED RADICAL MASTECTOMY.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Analgesic efficacy VAS scale
Study Overview
Brief Summary
Adequate post operative analgesia with minimal side effects is major concern of post anaesthesia care.
Ropivacaine known to be significantly lower toxic effect than racemic Bupivacaine, it is less potent than Bupivacaine when used at equal concentration.
Levobupivacine the s enantiomer of racemic Bupivacaine is associated with greater safety with regard to cardiotoxic and neurotoxicity. It is also found that it is equipotent to racemic Bupivacaine.
This prospective study is proposed to compare analgesic efficacy in modified radical mastectomy.
Study Design
- Study Type
- Interventional
- Allocation
- Computer generated randomization
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 20.00 Year(s) to 65.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •ASA 1 and 2 Consenting patient Weight 50-70kg.
Exclusion Criteria
- •Patient refusal History of allergy Severe renal liver cardiac and pulmonary dysfunction Unable to comprehend VAS scale.
Outcomes
Primary Outcomes
Analgesic efficacy VAS scale
Time Frame: Post operatively 0min, 15min, 30min, 45min, 60min,90min,2,4,8,12,16,20 and 24hours.
Secondary Outcomes
- Requirements of rescue analgesia(Incidence and severity of side effect)
